From a small corner drugstore, United Laboratories,
Inc. (UNILAB) has grown to become the country’s leading pharmaceutical company
with over 20 percent market share in an industry dominated by the world's biggest
Unilab develops, manufactures, and markets over 300 prescription and consumer
brands covering the major therapeutic categories
from common illnesses, like cough, colds, pain, allergy, and fever, to diseases
like hypertension, high cholesterol, diabetes, asthma, infections, tuberculosis,
ulcer, anemia, and cancer.
Many of Unilab’s products are now leading brands in the Philippines
, with a few recognized leaders even in Southeast Asia . Unilab’s products
are made available under the umbrella of Unilab’s twin advocacy programs
– Pharmacoeconomics and Pharmacovigilance – which ensure the efficacy,
safety, and affordability of Unilab’s healthcare products.
Aside from the Philippines , Unilab operates in ten other countries in Southeast
Asia : Cambodia , China , Hong Kong , Indonesia , Laos , Malaysia , Myanmar ,
Singapore , Sri Lanka , Thailand , and Veitnam. The major Unilab manufacturing
complex in Metro Manila has been cited by international health organizations as
one of the finest in Asia . A new and state-of-the-art manufacturing complex has
been inaugurated, which will exceed the current facility in both scale and technical
capability -- a clear evidence of Unilab's sustained commitment to product quality,
operational excellence, and continuing improvement.